Access to medicines and treatment: latest news

Access to medicines and treatment resources

Access to medicines and treatment features

Access to medicines and treatment news from aidsmap

More news

Access to medicines and treatment news selected from other sources

  • A simple ask in 2016: the UN goal of universal HIV treatment

    Last week, the working draft for 2016 UN Political Declaration on HIV/AIDS was released with only a few days for comments. Called the Zero draft, like previous statements produced every five years, it is a list of observations, comments and goals. But using the UN Statement as a platform of human rights has become disconnected from the scientific and medical advances in HIV over the last five years. The bulk of the draft document could have been written at any time during the epidemic, certainly most of it could have been written in 2011. There is only one reference to dramatic changes in the WHO 2015 guidelines and only two references to PrEP.

    20 hours ago | i-Base
  • Namibia: Over 144 000 On ARV Treatment

    Close to 144 000 people are on antiretroviral (ARV) treatment countrywide, according to the latest statistics released by the Ministry of Health and Social Services.

    26 April 2016 | AllAfrica
  • New York Insurers to Change Coverage of Hepatitis C Drugs

    Seven health-insurance companies in New York will change their criteria for covering costly drugs that cure chronic hepatitis C under the terms of agreements with the office of State Attorney General Eric Schneiderman.

    26 April 2016 | Wall Street Journal
  • ViiV Healthcare, Medicines Patent Pool Extend Licence for Dolutegravir to All Lower Middle-Income Countries

    The Medicines Patent Pool (MPP) and ViiV Healthcare announced an extension of their current licensing agreement today to increase access to dolutegravir (DTG), a promising new antiretroviral, to cover all remaining lower middle-income countries. The amendment to the 2014 licence specifically allows generic medicine distribution in four countries with patents - Armenia, Moldova, Morocco and Ukraine - that were not covered in the initial agreement. MPP sub-licensees can now sell in countries that are home to 94% of people living with HIV in the developing world.

    25 April 2016 | ViiV Healthcare press release
  • This Pill Prevents HIV—But It's Treated Like An Illicit Drug

    Around the world, people have to jump through hoops, and sometimes break laws, just to get it.

    23 April 2016 | Vocativ
  • How Can We Help Young People Under Age 18 Get PrEP?

    Getting PrEP into the hands of young people at high risk for HIV infection is a priority that experts are now discussing. A recent webinar and Q&A session hosted by HIVE brought together PrEP providers from across the country to talk about some of these issues and share successes and challenges.

    22 April 2016 | BETA blog
  • Fight against HIV doomed to fail without urgent focus on West and Central Africa

    Globally agreed goals to curb the HIV epidemic by 2020 will not be met unless the HIV response is drastically accelerated in West and Central Africa, where people living with HIV continue to suffer needlessly and die silently, Médecins Sans Frontières (MSF) warned in a new report released today.

    20 April 2016 | MSF
  • Hepatitis C: no more treatment rationing; universal access to generic medicines everywhere!

    People with hepatitis C virus (HCV) and their allies from Spain and around the world have gathered at the International Liver Congress to protest the outrageous price of life-saving HCV medicines. They are pushing for generic competition to bring down the price of HCV treatment and ensure universal access.

    18 April 2016 | Treatment Action Group
  • Cryptococcal meningitis: a blind spot in curbing AIDS

    Cryptococcal meningitis, a co-infection of HIV, is a leading killer of patients with AIDS worldwide. Yet it receives little global attention.

    15 April 2016 | The Lancet (requires free registration)
  • Innovative new programme set to treat 10,000 patients co-infected with hepatitis C and HIV in Africa and Asia

    The World Hepatitis Alliance welcomes the announcement of a new programme initiated by the Clinton Health Access Initiative, Inc. (CHAI) and AmeriCares that aims to treat 10,000 co-infected HIV and hepatitis C patients in Africa and Asia with new hepatitis C treatment Daklinza (daclatasvir).

    14 April 2016 | World Hepatitis Alliance
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.